Package 42806-414-05

{"route": ["ORAL"], "spl_id": "4bde5d2f-85ee-95da-e063-6394a90aab81", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["f79d1422-a9b6-41c2-a46d-22886605f94d"], "manufacturer_name": ["Epic Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42806-414-05)", "package_ndc": "42806-414-05", "marketing_start_date": "20230430"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42806-414-09)", "package_ndc": "42806-414-09", "marketing_start_date": "20230430"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (42806-414-30)", "package_ndc": "42806-414-30", "marketing_start_date": "20230430"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "42806-414_4bde5d2f-85ee-95da-e063-6394a90aab81", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "42806-414", "generic_name": "bupropion hydrochloride", "labeler_name": "Epic Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210015", "marketing_category": "ANDA", "marketing_start_date": "20230430", "listing_expiration_date": "20271231"}